BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30877210)

  • 1. Factors Associated with Relapse and Dependence on Glucocorticoids in Giant Cell Arteritis.
    Dumont A; Parienti JJ; Delmas C; Boutemy J; Maigné G; Martin Silva N; Sultan A; Planchard G; Aouba A; de Boysson H
    J Rheumatol; 2020 Jan; 47(1):108-116. PubMed ID: 30877210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?
    de Boysson H; Liozon E; Lambert M; Dumont A; Boutemy J; Maigné G; Martin Silva N; Ly KH; Manrique A; Bienvenu B; Aouba A
    Am J Med; 2017 Aug; 130(8):992-995. PubMed ID: 28460851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis.
    Banerjee S; Quinn KA; Gribbons KB; Rosenblum JS; Civelek AC; Novakovich E; Merkel PA; Ahlman MA; Grayson PC
    J Rheumatol; 2020 Jan; 47(1):99-107. PubMed ID: 30877209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular calcification in patients with large-vessel vasculitis compared to patients with hyperlipidemia.
    Banerjee S; Bagheri M; Sandfort V; Ahlman MA; Malayeri AA; Bluemke DA; Yao J; Grayson PC
    Semin Arthritis Rheum; 2019 Jun; 48(6):1068-1073. PubMed ID: 30318124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of large vessel involvement in large vessel vasculitis.
    Vautier M; Dupont A; de Boysson H; Comarmond C; Mirault T; Mekinian A; Lambert M; Ferfar Y; Aouba A; Cacoub P; Resche-Rigon M; Saadoun D
    J Autoimmun; 2020 Mar; 108():102419. PubMed ID: 32035747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.
    Koster MJ; Yeruva K; Crowson CS; Muratore F; Labarca C; Warrington KJ
    J Rheumatol; 2019 May; 46(5):501-508. PubMed ID: 30647171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of fluorine-18-fluorodeoxyglucose positron emission tomography in the diagnosis and monitoring of large vessel vasculitis: A South Australian retrospective audit.
    Nguyen AD; Crowhurst T; Lester S; Dobson R; Bartholomeusz D; Hill C
    Int J Rheum Dis; 2019 Aug; 22(8):1378-1382. PubMed ID: 31211510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
    Monti S; Águeda AF; Luqmani RA; Buttgereit F; Cid M; Dejaco C; Mahr A; Ponte C; Salvarani C; Schmidt W; Hellmich B
    RMD Open; 2019; 5(2):e001003. PubMed ID: 31673411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study.
    Prieto-González S; García-Martínez A; Tavera-Bahillo I; Hernández-Rodríguez J; Gutiérrez-Chacoff J; Alba MA; Murgia G; Espígol-Frigolé G; Sánchez M; Arguis P; Cid MC
    Medicine (Baltimore); 2015 Feb; 94(5):e486. PubMed ID: 25654393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
    Hellmich B; Agueda A; Monti S; Buttgereit F; de Boysson H; Brouwer E; Cassie R; Cid MC; Dasgupta B; Dejaco C; Hatemi G; Hollinger N; Mahr A; Mollan SP; Mukhtyar C; Ponte C; Salvarani C; Sivakumar R; Tian X; Tomasson G; Turesson C; Schmidt W; Villiger PM; Watts R; Young C; Luqmani RA
    Ann Rheum Dis; 2020 Jan; 79(1):19-30. PubMed ID: 31270110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.
    Alibaz-Öner F; Kelesoglu B; Balci MA; Yardimci GK; Armağan B; Kiliç L; Karakaş Ö; Erden A; Yasar Bilge S; Kardaş RC; Küçük H; Zengin O; Tasci M; Kocaer SB; Yavuz S; Dogru A; Şahin M; Bayindir O; Sevik G; Ertürk Z; Alpay-Kanitez N; Gogebakan H; Tezcan ME; Oksuz MF; Cefle A; Kucuksahin O; Yazici A; Kasapoglu E; Bes C; Unal AU; Dalkiliç E; Yildirim Çetin G; Aksu K; Keser G; Onen F; Çobankara V; Kisacik B; Onat AM; Öztürk MA; Kaşifoğlu T; Omma A; Karadag O; Ates A; Direskeneli H
    Clin Exp Rheumatol; 2024 Apr; 42(4):816-821. PubMed ID: 37976117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
    Hellmich B; Águeda AF; Monti S; Luqmani R
    Curr Rheumatol Rep; 2020 Oct; 22(12):84. PubMed ID: 33044642
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Grayson PC; Alehashemi S; Bagheri AA; Civelek AC; Cupps TR; Kaplan MJ; Malayeri AA; Merkel PA; Novakovich E; Bluemke DA; Ahlman MA
    Arthritis Rheumatol; 2018 Mar; 70(3):439-449. PubMed ID: 29145713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.
    Palmowski A; Buttgereit F
    Curr Rheumatol Rep; 2020 Oct; 22(12):85. PubMed ID: 33047263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing treatment options for large vessel vasculitis.
    Macaluso F; Marvisi C; Castrignanò P; Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2022 Aug; 18(8):793-805. PubMed ID: 35714219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab: a novel therapy for patients with large-vessel vasculitis.
    Salvarani C; Magnani L; Catanoso M; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
    Rheumatology (Oxford); 2012 Jan; 51(1):151-6. PubMed ID: 22075063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?
    Furuta S; Cousins C; Chaudhry A; Jayne D
    J Rheumatol; 2015 Feb; 42(2):300-8. PubMed ID: 25399386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic dilatation in patients with large vessel vasculitis: A longitudinal case control study using PET/CT.
    Muratore F; Crescentini F; Spaggiari L; Pazzola G; Casali M; Boiardi L; Pipitone N; Croci S; Galli E; Aldigeri R; Versari A; Salvarani C
    Semin Arthritis Rheum; 2019 Jun; 48(6):1074-1082. PubMed ID: 30424972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-vessel involvement is predictive of multiple relapses in giant cell arteritis.
    de Mornac D; Espitia O; Néel A; Connault J; Masseau A; Espitia-Thibault A; Artifoni M; Achille A; Wahbi A; Lacou M; Durant C; Pottier P; Perrin F; Graveleau J; Hamidou M; Hardouin JB; Agard C
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211009029. PubMed ID: 34046092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.